Precision prevention trials are biologically driven interception studies conducted in high cancer risk groups. These are smaller, potentially faster, cheaper, and more commercially attractive than traditional large-scale population prevention studies. In this article, we discuss the key challenges of conducting precision prevention research and their mitigations.
10.1158/1940-6207.CAPR-25-0035
Journal article
2025-09-02T00:00:00+00:00
18
499 - 507
8
Humans, Neoplasms, Precision Medicine, Clinical Trials as Topic